BeStock  
Stocks › Biotechnology › RGNX

Regenxbio RGNX

US equityMarket cap rank #3612Biotechnology
$7.16 −$0.02 (-0.28%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $7.12 -0.56%
Open$7.00
Prev close$7.18
Day range$6.86 – $7.30
Volume1.06M
Market cap$473.44M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$9.16M-69.2% YoY
Operating profit-$73.56M-40.4% YoY
Net profit-$40.74M+34.2% YoY
Diluted EPS-$0.62+48.3% YoY
Free cash flow$38.42M+168.1% YoY
Operating cash flow$38.61M

Revenue, last 8 quarters

$21.2MDec '24$89.0MMar '25$21.4MJun '25$29.7MSep '25$30.3MDec '25$6.4MMar '26$108.0MJun '26$9.2MSep '26

Net profit, last 8 quarters

$-51.2MDec '24$6.1MMar '25$-70.9MJun '25$-61.9MSep '25$-67.1MDec '25$-90.1MMar '26$22.7MJun '26$-40.7MSep '26

Diluted EPS by quarter

-1.01Dec '240.12Mar '25-1.38Jun '25-1.20Sep '25-1.30Dec '25-1.72Mar '260.43Jun '26-0.62Sep '26

Free cash flow by quarter

$-32.7MDec '24$32.6MMar '25$-49.7MJun '25$-56.5MSep '25$-52.8MDec '25$-77.4MMar '26$-63.0MJun '26$38.4MSep '26

Annual revenue

$154.6MFY20$470.3MFY21$112.7MFY22$90.2MFY23$83.3MFY24$170.4MFY25

Profitability & balance sheet

Gross margin87.5%
Operating margin-120.4%
Net margin-113.9%
Return on equity-113.2%
Return on assets-35.4%
Return on invested capital-61.5%
Current ratio4.74
Liabilities / assets68.2%
Cash & investments$250.98M
Total debt$60.05M
Net cash (debt)$190.92M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $9.16M $108.02M $6.39M $170.44M $30.34M
Total Operating Revenue $9.16M $108.02M $6.39M $170.44M $30.34M
Cost of Revenue $1.14M $1.04M $11.07M $20.30M $5.93M
Gross Profit $8.02M $106.98M -$4.68M $150.14M $24.41M
Operating Expense $81.58M $77.71M $78.68M $311.34M $82.05M
Selling and Admin Expenses $20.58M $21.62M $21.31M $82.86M $22.38M
-General & Admin Expense $20.58M $21.62M $21.31M $82.86M $22.38M
Research & Development $61.01M $56.09M $57.34M $228.30M $59.61M
Other Operating Expenses -$7,000.00 $12,000.00 $36,000.00 $179,000.00 $54,000.00
Operating Profit -$73.56M $29.26M -$83.36M -$161.20M -$57.64M
Net Non-Operating Interest Income (Expense) -$7.46M -$7.78M -$8.69M -$44.93M -$12.26M
Non-Operating Interest Income $16,000.00 $17,000.00 $16,000.00 $83,000.00 $18,000.00
Non-Operating Interest Expense $7.47M $7.79M $8.71M $45.01M $12.28M
Other Income (Expense) $40.28M $1.22M $2.00M $12.25M $2.75M
Gain on Sale of Security $2.25M $1.22M $2.00M $12.25M $2.75M
Special Income (Charges) $38.03M – – $0.00 $0.00
-Less:Other Special Charges -$38.03M – – – –
Pretax Profit -$40.74M $22.71M -$90.05M -$193.88M -$67.15M
Net Profit -$40.74M $22.71M -$90.05M -$193.88M -$67.15M
Profit from Continuing Operations -$40.74M $22.71M -$90.05M -$193.88M -$67.15M
Net Income to Parent Company -$40.74M $22.71M -$90.05M -$193.88M -$67.15M
Net Income to Common Stockholders -$40.74M $22.71M -$90.05M -$193.88M -$67.15M
Basic EPS -$0.62 $0.43 -$1.72 -$3.76 -$1.30
Diluted EPS -$0.62 $0.43 -$1.72 -$3.76 -$1.30
Asset Impairment Loss – – – $0.00 –
-Less:Impairment of Capital Assets – – – $0.00 $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $466.04M $386.62M $341.89M $453.03M $453.03M
Total Current Assets $320.89M $236.16M $186.52M $281.28M $281.28M
Cash and Cash Equivalents & Short-Term Investments $250.98M $105.52M $150.49M $230.07M $230.07M
-Cash and Cash Equivalents $95.80M $36.49M $15.23M $34.47M $34.47M
-Short Term Investments $155.18M $69.03M $135.26M $195.60M $195.60M
Receivables $9.50M $107.10M $10.94M $27.38M $27.38M
-Accounts Receivable $1.17M $100.39M $2.80M $557,000.00 $557,000.00
-Accrued Interest Receivable $961,000.00 $348,000.00 $902,000.00 $1.00M $1.00M
-Other Receivables $7.36M $6.37M $7.24M $25.82M $25.82M
Prepaid Assets $13.01M $11.90M $11.54M $11.93M $11.93M
Restricted Cash $225,000.00 $225,000.00 – – –
Other Current Assets $47.19M $11.41M $13.54M $11.90M $11.90M
Total Non-Current Assets $145.15M $150.46M $155.38M $171.75M $171.75M
Net PPE $137.59M $142.32M $147.42M $152.01M $152.01M
-Gross PPE $234.58M $236.25M $238.42M $239.20M $239.20M
-Accumulated Depreciation -$96.99M -$93.93M -$91.01M -$87.19M -$87.19M
Investments and Advances $0.00 $0.00 $0.00 $10.79M $10.79M
Non Current Accounts Receivables $450,000.00 $435,000.00 $420,000.00 $2.31M $2.31M
Other Non-Current Assets $7.11M $7.71M $7.54M $6.64M $6.64M
Total Liabilities $318.00M $314.85M $320.81M $350.30M $350.30M
Total Current Liabilities $67.68M $82.62M $71.11M $118.10M $118.10M
Payables $13.48M $15.55M $21.21M $21.36M $21.36M
-Accounts Payable $13.48M $15.55M $21.21M $21.36M $21.36M
Current Accrued Expenses $13.57M $10.11M $12.53M $20.97M $20.97M
Short-Term Debt and Capital Lease Obligation $6.49M $7.36M $7.87M $8.29M $8.29M
-Current Capital Lease Obligation $6.49M $7.36M $7.87M $8.29M $8.29M
Current Deferred Liabilities $5.99M $9.88M $5.92M $10.45M $10.45M
Other Current Liabilities $12.11M $26.77M $14.23M $39.61M $39.61M
Total Non-Current Liabilities $250.31M $232.23M $249.70M $232.20M $232.20M
Long Term Debt and Capital Lease Obligation $60.05M $61.60M $63.20M $65.22M $65.22M
-Long Term Capital Lease Obligation $60.05M $61.60M $63.20M $65.22M $65.22M
Non-Current Deferred Liabilities $16.22M $15.40M $22.78M $18.94M $18.94M
Other Non-Current Liabilities $174.04M $155.23M $163.73M $148.05M $148.05M
Total Equity $148.04M $71.77M $21.08M $102.73M $102.73M
Stockholders' Equity $148.04M $71.77M $21.08M $102.73M $102.73M
Capital Stock $7,000.00 $5,000.00 $5,000.00 $5,000.00 $5,000.00
-Common Stock $7,000.00 $5,000.00 $5,000.00 $5,000.00 $5,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.38B $1.27B $1.24B $1.23B $1.23B
Retained Earnings -$1.23B -$1.19B -$1.22B -$1.13B -$1.13B
Gains/Losses Not Affecting Retained Earnings -$1.05M -$875,000.00 -$870,000.00 -$687,000.00 -$687,000.00
-Available for Sale Securities – – – $10.79M $10.79M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $38.61M -$62.24M -$76.19M -$123.96M -$52.29M
Net cash flow from continuing operations $38.61M -$62.24M -$76.19M -$123.96M -$52.29M
Net Income from Continuing Operations -$40.74M $22.71M -$90.05M -$193.88M -$67.15M
Gain/Loss from Continuing Operations $0.00 – – -$62,000.00 $0.00
Depreciation & Depletion & Amortization $3.52M $3.76M $3.86M $15.62M $3.87M
Other Non-Cash Items $7.48M $5.54M $2.89M $13.50M $5.64M
Change in Working Capital $61.91M -$103.28M -$1.50M $11.78M -$1.80M
-Change in Receivables $98.22M -$96.71M $18.25M -$7.66M -$561,000.00
-Change in Prepaid Assets -$1.11M -$361,000.00 $384,000.00 -$2.86M $1.02M
-Change in Payables and Accrued Expense $4.46M -$4.12M -$16.39M -$2.06M -$1.82M
-Change in Other Current Assets -$34.17M $3.57M -$509,000.00 $6.70M $7.56M
-Change in Other Current Liabilities -$2.42M -$2.25M -$2.54M -$11.62M -$3.02M
-Change In Other Working Capital -$3.08M -$3.41M -$700,000.00 $29.28M -$4.99M
Net cash flow from investing -$86.15M $65.93M $70.59M -$15.87M $37.54M
Net Cash Flow from Continuing Investing Activities -$86.15M $65.93M $70.59M -$15.87M $37.54M
Net PPE Purchase and Sale -$194,000.00 -$760,000.00 -$1.24M -$2.41M -$508,000.00
Net Investment Purchase and Sale -$85.96M $66.69M $71.82M -$13.45M $38.05M
Financing Cash Flow $106.85M $17.57M -$13.64M $116.77M -$9.58M
Net Cash Flow from Continuing Financing Activities $106.85M $17.57M -$13.64M $116.77M -$9.58M
Net Issuance Payments Of Debt $0.00 – – $144.49M $0.00
Net Common Stock Issuance $108.67M $19.50M $648,000.00 $1.05M $0.00
Proceeds from Stock Option Exercised $647,000.00 $51,000.00 $146,000.00 $318,000.00 $90,000.00
Net Other Financing Charges -$2.47M -$1.98M -$14.43M -$29.09M -$9.67M
Ending Cash Balance $97.83M $38.52M $17.26M $36.50M $36.50M
Net Change in Cash $59.31M $21.26M -$19.24M -$23.06M -$24.34M
Beginning Cash Balance $38.52M $17.26M $36.50M $59.56M $60.83M
Free Cash Flow $38.42M -$63.00M -$77.42M -$126.38M -$52.80M

Discussion

No comments yet — be the first to weigh in on RGNX.

Sign in to join the discussion.

Scroll to Top